Joost Bart

6.6k citations

83 papers · 5.2k · 2 hit papers · h-index 31

Impact in

Oncology top 1%
- Drug Transport and Resistance Mechanisms
- HER2/EGFR in Cancer Research
Cancer Research top 2%
- Breast Cancer Treatment Studies

Papers in

Oncology 34
- Drug Transport and Resistance Mechanisms 13
- HER2/EGFR in Cancer Research 7
- Cancer Immunotherapy and Biomarkers 5
Reproductive Medicine 16
- Ovarian cancer diagnosis and treatment 14

Co-authors: N. Harry Hendrikse (12 shared papers)Willem Vaalburg (11 shared papers)Gooitzen M. van Dam (10 shared papers)Rick G. Pleijhuis (4 shared papers)Elisabeth G.E. de Vries (16 shared papers)Johannes S. de Jong (2 shared papers)Lucia M.A. Crane (5 shared papers)Antoon T. M. Willemsen (4 shared papers)
Journals: Histopathology (4 papers)The Journal of Clinical Pharmacology (3 papers)Gynecologic Oncology (3 papers)International Journal of Gynecological Cancer (2 papers)Journal of Nuclear Medicine (2 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Joost Bart

77 papers receiving 5.1k citations

Joost Bart's Hit Papers

align trajectories log scale

Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results 2011 · 1.3k citations

Peers

Countries citing papers authored by Joost Bart

Since Specialization

Citations

This map shows the geographic impact of Joost Bart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joost Bart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joost Bart more than expected).

Fields of papers citing papers by Joost Bart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joost Bart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joost Bart. The network helps show where Joost Bart may publish in the future.

Co-authors

The 25 scholars most cited alongside Joost Bart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joost Bart Line = papers co-authored together Joost Bart links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results Nature Medicine ·Gooitzen M. van Dam, George Themelis, Lucia M.A. Crane, Niels J. Harlaar, Rick G. Pleijhuis, Wendy Kelder, Athanasios Sarantopoulos, Johannes S. de Jong, Henriëtte J.G. Arts, Ate G.J. van der Zee, Joost Bart, Philip S. Low, Vasilis Ntziachristos Hit paper breakdown →	2011	1321
2	Blood–brain barrier dysfunction in parkinsonian midbrain in vivo Annals of Neurology ·Rudie Kortekaas, Klaus L. Leenders, Joost C.H. van Oostrom, Willem Vaalburg, Joost Bart, Antoon T. M. Willemsen, N. Harry Hendrikse Hit paper breakdown →	2005	620
3	Development and Characterization of Clinical-Grade ⁸⁹Zr-Trastuzumab for HER2/neu ImmunoPET Imaging Journal of Nuclear Medicine ·Eli Dijkers, Jos G. W. Kosterink, Anna P. Rademaker, Lars R. Perk, Guus A.M.S. van Dongen, Joost Bart, Johan R. de Jong, Elisabeth G.E. de Vries, Marjolijn N. Lub–de Hooge	2009	282
4	Obtaining Adequate Surgical Margins in Breast-Conserving Therapy for Patients with Early-Stage Breast Cancer: Current Modalities and Future Directions Annals of Surgical Oncology ·Rick G. Pleijhuis, Maurits Graafland, Jakob de Vries, Joost Bart, Johannes S. de Jong, Gooitzen M. van Dam	2009	265
5	Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma BMC Cancer ·Liqiang Qi, Joost Bart, (unknown), Inge Platteel, Tineke van der Sluis, Sippie Huitema, Geert Harms, Li Fu, Harry Hollema, Anke van den Berg	2009	193
6	Receptor conversion in distant breast cancer metastases Breast Cancer Research ·Laurien D.C. Hoefnagel, Marc J. van de Vijver, Henk-Jan van Slooten, Pieter Wesseling, Jelle Wesseling, Pieter J. Westenend, Joost Bart, Cornelis A. Seldenrijk, Irıs D. Nagtegaal, Joost J. Oudejans, Paul van der Valk, Petra van der Groep, Elisabeth G.E. de Vries, Elsken van der Wall, P. J. van Diest	2010	183
7	The blood-brain barrier and oncology: new insights into function and modulation Cancer Treatment Reviews ·Joost Bart, H.J.M. Groen, N. Harry Hendrikse, Winette T.A. van der Graaf, Willem Vaalburg, Elisabeth G.E. de Vries	2000	153
8	An oncological view on the blood–testis barrier The Lancet Oncology ·Joost Bart, Harry J.M. Groen, Winette T.A. van der Graaf, Harry Hollema, N. Harry Hendrikse, Willem Vaalburg, Dirk Th. Sleijfer, Elisabeth G.E. de Vries	2002	149
9	Preclinical characterisation of ¹¹¹In‐DTPA‐trastuzumab British Journal of Pharmacology ·Marjolijn N. Lub‐de Hooge, Jos G. W. Kosterink, Patrick J. Perik, Hugo Nijnuis, Ly Tran, Joost Bart, Albert J.H. Suurmeijer, Steven de Jong, Pieter L. Jager, Elisabeth G.E. de Vries	2004	143
10	The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood–testis barrier and in primary testicular tumours European Journal of Cancer ·Joost Bart, Harry Hollema, Harry J.M. Groen, Elisabeth G.E. de Vries, N. Harry Hendrikse, Dirk Th. Sleijfer, Theodora D Wegman, Willem Vaalburg, Winette T.A. van der Graaf	2004	138
11	⁸⁹Zr-Bevacizumab PET Imaging in Primary Breast Cancer Journal of Nuclear Medicine ·Sietske B.M. Gaykema, Adrienne H. Brouwers, Marjolijn N. Lub–de Hooge, Rick G. Pleijhuis, Hetty Timmer‐Bosscha, Linda Pot, Gooitzen M. van Dam, Sibylle B. van der Meulen, Johan R. de Jong, Joost Bart, Jakob de Vries, Liesbeth Jansen, Elisabeth G.E. de Vries, Carolien P. Schröder	2013	136
12	Blood–brain barrier P-glycoprotein function decreases in specific brain regions with aging: A possible role in progressive neurodegeneration Neurobiology of Aging ·Anna L. Bartels, Rudie Kortekaas, Joost Bart, Antoon T. M. Willemsen, Onno L. de Klerk, Jeroen J. de Vries, Joost C.H. van Oostrom, Klaus L. Leenders	2008	131
13	PET Studies on P-Glycoprotein Function in the Blood-Brain Barrier: How it Affects Uptake and Binding of Drugs within the CNS Current Pharmaceutical Design ·Philip H. Elsinga, N. Harry Hendrikse, Joost Bart, Willem Vaalburg, Aren van Waarde	2004	131
14	Potentiation of a p53‐SLP vaccine by cyclophosphamide in ovarian cancer: A single‐arm phase II study International Journal of Cancer ·Renee Vermeij, Ninke Leffers, Baukje‐Nynke Hoogeboom, Ineke L.E. Hamming, Rinze Wolf, Anna K.L. Reyners, Barbara H. W. Molmans, Harry Hollema, Joost Bart, Jan W. Drijfhout, Jaap Oostendorp, Ate G.J. van der Zee, Cornelis J.M. Melief, Sjoerd H. van der Burg, Toos Daemen, Hans W. Nijman	2011	80
15	Support of the ‘fallopian tube hypothesis’ in a prospective series of risk-reducing salpingo-oophorectomy specimens European Journal of Cancer ·Welmoed Reitsma, Geertruida H. de Bock, Jan C. Oosterwijk, Joost Bart, Harry Hollema, Marian J.E. Mourits	2012	77
16	Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases Cancer ·Laurien D.C. Hoefnagel, Cathy B. Moelans, Sybren L. Meijer, Henk-Jan van Slooten, Pieter Wesseling, Jelle Wesseling, Pieter J. Westenend, Joost Bart, Cornelis A. Seldenrijk, Irıs D. Nagtegaal, Joost J. Oudejans, Paul van der Valk, Carla H. van Gils, Elsken van der Wall, P. J. van Diest	2012	75
17	Quantitative assessment of P-glycoprotein function in the rat blood–brain barrier by distribution volume of [11C]verapamil measured with PET NeuroImage ·Joost Bart, Antoon T. M. Willemsen, Harry J.M. Groen, Winette T.A. van der Graaf, Theodora D Wegman, Willem Vaalburg, Elisabeth G.E. de Vries, N. Harry Hendrikse	2003	70
18	Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool Translational Oncology ·Marleen van Oosten, Lucia M.A. Crane, Joost Bart, Fijs W. B. van Leeuwen, Gooitzen M. van Dam	2011	69
19	The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer Cellular Oncology ·Lucia M.A. Crane, Henriëtte J.G. Arts, Marleen van Oosten, Philip S. Low, Ate G.J. van der Zee, Gooitzen M. van Dam, Joost Bart	2011	66
20	Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach Breast Cancer Research ·Tim Dekker, Susan ter Borg, Gerrit K. Hooijer, Sybren L. Meijer, Jelle Wesseling, James E. Boers, Ed Schuuring, Joost Bart, Joost van Gorp, Wilma E. Mesker, Judith R. Kroep, Vincent T.H.B.M. Smit, Marc J. van de Vijver	2012	49

About Joost Bart

Joost Bart is a scholar working on Oncology, Reproductive Medicine, Pediatrics, Perinatology and Child Health, Surgery and Radiology, Nuclear Medicine and Imaging, having authored 83 papers that have together received 5.2k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (14 papers), Drug Transport and Resistance Mechanisms (13 papers), Pharmacological Effects and Toxicity Studies (12 papers), Breast Cancer Treatment Studies (7 papers), HER2/EGFR in Cancer Research (7 papers), Epilepsy research and treatment (7 papers), BRCA gene mutations in cancer (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (649 citations), Neurology (348 citations), Radiology, Nuclear Medicine and Imaging (921 citations) and Reproductive Medicine (324 citations). Joost Bart has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include N. Harry Hendrikse, Willem Vaalburg, Gooitzen M. van Dam, Rick G. Pleijhuis, Elisabeth G.E. de Vries, Johannes S. de Jong, Lucia M.A. Crane, Antoon T. M. Willemsen, George Themelis and Vasilis Ntziachristos. Their work appears in journals such as Histopathology, The Journal of Clinical Pharmacology, Gynecologic Oncology, International Journal of Gynecological Cancer and Journal of Nuclear Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Joost Bart

Impact in

Papers in i

In The Last Decade

Joost Bart

Joost Bart's Hit Papers

Peers

Countries citing papers authored by Joost Bart

Fields of papers citing papers by Joost Bart

All Works

About Joost Bart

Explore authors with similar magnitude of impact

Papers in